Momenta Pharmaceuticals Exercises Option To Acquire Novel Antibody Program From AnaptysBio
September 08, 2014 at 08:30 AM EDT
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a ...
